The findings indicated that the treatment targets were primarily enriched in pathways such as the “AGE-RAGE signaling pathway in diabetic complications,” “IL-17 signaling pathway,” “p53 signaling pathway,” and “TNF signaling pathway.” These pathways exert substantial influence on the release of inflammatory factors, thereby impacting UC and T2DM. Here, RENBP is linked to type 2 diabetes mellitus.